Xcout Intel
Prokarium competitors & alternatives
The 12 closest competitors and alternatives to Prokarium among healthcare companies — ranked by similarity to what Prokarium actually does, not by market-cap band.
Subscribe to see Prokarium’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Prokarium
Prokarium is a biotechnology research company headquartered in London, United Kingdom, focused on developing targeted immunotherapies like its investigational treatment ZH9.
Prokarium at a glance
Prokarium is a healthcare company headquartered in United Kingdom. It has raised at least $45.7M across the 3 funding rounds on record. Its most recent funding round raised $30M in February 2023. Xcout tracks 6 named people at Prokarium, including Ibs Mahmood (CEO).
Prokarium leadership
- Ibs MahmoodCEO
- Dara HenryCOO
- Julia JonesCFO
- Josi HolzCMO
- Livija DebanCSO
- Nick GlanvilleVP of Research
Prokarium funding rounds
At least $45.7M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $30M | 2 named | |
| — | $5.7M | 1 named | |
| Series A | $10M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Prokarium competitors
Ranked by semantic similarity — how close each company is to Prokarium by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthcare company
PDC*line Pharma is a clinical-stage biotechnology company headquartered in Liège, Belgium, focused on developing innovative cell therapies and cancer vaccines.
Similar healthcare company
Healome Therapeutics is an eye care therapeutics company headquartered in Birmingham, United Kingdom. The company focuses on developing more effective, safer, and practical treatments for vision-threatening ocular surface diseases.
Similar healthcare company
Vantage Biosciences is a clinical-stage biotechnology company headquartered in London, United Kingdom. Founded in 2023, the firm focuses primarily on advancements and clinical trials in the field of ophthalmology. It manages drug pipelines and pharmaceutical research out of its London office.
Similar healthcare company
Harbour BioMed is a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology.
Similar healthcare company
Zhejiang DTRM Biopharma Co. Ltd. is an oncology-focused biopharmaceutical company that develops, produces, and sells pharmaceutical products, including immunotherapy drugs and small molecule therapies for cancer and immune diseases. The company's pipeline features assets such as BTK inhibitors and combination therapies.
Similar healthcare company
Infinitopes is a biotechnology research company based in Oxford, United Kingdom, focused on developing revolutionary off-the-shelf precision vaccines to prevent deaths from cancer metastases.
Similar healthcare company
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Health Care
ExpreS2ion Biotech Holding is a clinical-stage biotechnology company that develops innovative immunotherapies and vaccines to treat cancer and prevent infectious diseases. Utilizing its proprietary ExpreS2 protein expression system and a virus-like particle delivery platform, the company creates candidates such as its lead HER2 cancer immunotherapy, ES2B-C001.
Biotechnology
Centauri Therapeutics Limited is a privately held immunotherapy company with its primary headquarters located in London, United Kingdom.
Biotechnology
Akari Therapeutics, Plc is a clinical-stage biotechnology firm dedicated to advancing novel treatments for autoimmune and inflammatory disorders. The company's primary investigational therapy is nomacopan, an advanced, second-generation complement inhibitor. This drug is engineered to counteract both inflammatory and prothrombotic processes. Nomacopan holds promise for a range of serious conditions, including paroxysmal nocturnal hemoglobinuria (PNH), Guillain-Barré syndrome (GBS), hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), and bullous pemphigoid (BP). Akari's operations are headquartered in London, United Kingdom.
Life Sciences
Cytospire Therapeutics Limited is a biotechnology research company based in London, United Kingdom. The company is focused on developing a portfolio of next-generation immune cell engagers to improve patients' lives.
Biotech
KAHR Medical Ltd. is a clinical-stage health technology and biopharmaceutical company developing novel drug pipelines and dual-targeting protein therapeutics for immuno-oncology. The company is headquartered in Israel.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Prokarium and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Prokariumand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →